Neu Health Joins Global Incubator for U.S. Expansion in Neurology

Neu Health has been selected for the Global Incubator Programme (GIP): USA HealthTech - Medical Devices, announced in a press release. This six-month program, delivered by Innovate UK in partnership with Texas Medical Center Innovation (TMCi), aims to support UK medical device and digital health companies entering the U.S. market.

The program provides access to Houston's Texas Medical Center, the world's largest medical complex, which treats 10 million patients annually. This selection follows Neu Health's recent U.S. launch and FDA 510(k) clearance for its smartphone-based tool for measuring resting tremor in Parkinson's disease. The tool is the first fully phone-based system for measuring motor symptoms without wearable or in-clinic hardware.

Neu Health is already piloting its platform at Cedars-Sinai and Mass General Brigham, with further U.S. expansions planned. The GIP will enable Neu Health to connect with clinical leaders and investor networks, facilitating partnerships and growth opportunities in the U.S. market. The program runs from September 2025 to March 2026, combining virtual incubation with on-site immersion in Houston.